Discover the symptoms, treatment, and prevention of diphtheria. Find out how to protect yourself against this dangerous bacterial disease and why vaccination is crucial.
Table of Contents
- What is diphtheria and how does it spread?
- Most common symptoms of diphtheria in children and adults
- Diagnosis of diphtheria – how to detect the disease?
- Diphtheria treatment: effective methods and recommendations
- Why is diphtheria vaccination crucial?
- Complications and prevention of diphtheria – how to stay safe?
What is diphtheria and how does it spread?
Diphtheria, also known as diphtheria, is a serious, highly contagious bacterial disease caused by the diphtheria bacillus (Corynebacterium diphtheriae). This bacterium produces a very dangerous toxin that primarily attacks the mucous membranes of the throat, nasal cavity, and larynx, and sometimes other organs such as the skin or eyes. The key factor in the development of the disease is the diphtheria toxin, which is responsible for damaging body cells, particularly heart muscle, nerves, and kidneys. A characteristic sign of diphtheria is the appearance of grayish or gray-white pseudomembranes on the tonsils, throat, or other infected mucous membranes, which in severe cases may lead to significant narrowing of the airways and breathing difficulties. Diphtheria can have a very rapid course, leading even to death—mainly due to airway blockage or paralytic effects of the toxin on the heart or nervous system.
Infection most often occurs through droplet transmission, i.e. inhaling air containing bacteria present in the secretions of the throat, nose, or pharynx from an infected person or carrier. Other sources of infection may include direct contact with secretions (e.g. saliva on shared cutlery, cups, or towels), and in rare cases, contact with diseased skin. The bacterium can survive on surfaces (e.g. toys, door handles) for several hours, especially in humid environments, which increases the risk of transmission. People most at risk are those who have not been vaccinated or have not received booster doses. The disease can spread in crowded places such as kindergartens, schools, dormitories, nursing homes, or shelters, where contact with an infected person is easy. Asymptomatic carriers, who show no signs of illness but still shed and spread the bacteria, pose a particular risk. Another, less common route of infection is through broken skin, especially in the case of neglected wounds or ulcers—this is most common in hot, humid climates and in areas with poor hygiene. There is serious risk of illness in countries with insufficient immunization programs, and in crisis situations such as armed conflicts or mass migrations that disrupt vaccination programs and encourage outbreaks. Immunity acquired after vaccination or previous disease wanes over time, so regular booster shots according to the current vaccination schedule are essential. Remember that when traveling to countries where diphtheria is still present, you must make sure your vaccinations are up to date since even short-term exposure can lead to severe infection.
Most common symptoms of diphtheria in children and adults
Depending on its course, diphtheria may present in various clinical forms, and its first symptoms are often mistaken for typical upper respiratory tract infections. Usually, symptoms appear suddenly, 2–5 days after infection. In both children and adults, the disease usually starts as a moderate fever (most often between 38°C and 39°C), malaise, and gradually worsening sore throat. Noteworthy are also strong fatigue, poor appetite, and a general sense of weakness. A hallmark sign distinguishing diphtheria from other throat infections is the appearance of thick gray-white pseudomembranes covering the tonsils, posterior pharyngeal wall, uvula, and sometimes the soft palate. These pseudomembranes are difficult to remove—attempting to scrape them can cause bleeding. As the disease progresses, the pseudomembranes may expand and cause airway obstruction, resulting in shortness of breath, stridor, hoarseness, and a dry cough. Particularly concerning in children is inspiratory dyspnea, manifested by retractions between the ribs and flaring of nostrils while breathing. Without rapid treatment, the condition can worsen over time, leading to cyanosis from hypoxia and serious complications such as myocarditis or peripheral nerve palsies. In some cases, especially in young children, diphtheria can progress rapidly, causing the airway to become completely blocked in just a few days. Diphtheria is also characterized by enlarged, hard, and painful cervical lymph nodes, sometimes referred to as “bull neck” due to pronounced swelling of the neck’s soft tissues. Additionally, a sick person’s breath may have a sweetish, unpleasant odor; symptoms may include difficulty swallowing, pain while speaking, or even complete loss of voice in advanced cases. In severe infections, diphtheria can involve the nose, leading to chronic, purulent or serosanguinous discharge, often with gray crusts near the nostrils. Erosions and ulcers in the nasal mucosa are less common but occur more often in infants and small children with undeveloped immunity.
Differences in the clinical appearance of diphtheria also depend on the patient’s age and the site of infection. In adults, symptoms may be less pronounced or limited to mild sore throat, weakness, and minimal cervical swelling, making prompt diagnosis more challenging and increasing the chances of missing the disease. However, even a mild course does not rule out serious complications, as the bacterial toxin can damage organs regardless of how pronounced the local symptoms are. In atypical cases, diphtheria can also affect other body areas such as the skin (cutaneous diphtheria), conjunctiva, or genital organs, leading to chronic, difficult-to-heal ulcers covered with a gray membrane and localized swelling. Immunized individuals may experience a very mild, even asymptomatic, course of diphtheria, but can still transmit the bacteria to non-immune people. In addition to local symptoms, some patients show persistent low-grade fever, shortness of breath, tachycardia, skin paleness, headaches, and occasionally rash. In the most severe cases, the diphtheria toxin leads to multi-organ complications, especially toxic damage to the heart (arrhythmias, heart failure) and nervous system (nerve palsies, swallowing disorders, respiratory failure). The younger the patient, the more severe the course usually is, and immediate medical intervention is needed. Special attention should be paid to children, where even apparently mild symptoms may quickly worsen, posing a threat to life. Diphtheria is a rapidly progressing and insidious disease; accurate recognition and prompt treatment are essential to avoid dramatic health consequences in both children and adults.
Diagnosis of diphtheria – how to detect the disease?
The diagnostic process of diphtheria is based on thorough analysis of clinical symptoms, confirmed by specialized laboratory tests. Since the initial symptoms can resemble typical throat infections or influenza, physician awareness and detailed history-taking—including vaccination status, recent travel to endemic regions, and exposure to sick individuals—are critical. Particularly alarming are the characteristic gray-white membranes over the throat, tonsils, or larynx, which are difficult to remove and often leave a bleeding surface when scraped. Physical examination should pay attention to swelling of cervical lymph nodes and adjacent tissues, which may produce a “bull neck” appearance—an advanced stage marker. In suspected cases, be alert for overall health deterioration, shortness of breath, difficulty swallowing, and possible signs of complications, particularly cardiac and neurological. Rapid diagnosis is also important due to epidemic potential whenever a single case arises in an unvaccinated population or in the context of an increased local incidence.
Laboratory microbiological testing plays a crucial role in confirming the diagnosis. The primary test is swabbing the affected area (throat, tonsils, nose, or skin lesions if involved) before starting antibiotics. The sample is cultured on special selective media to allow detection of Corynebacterium diphtheriae strains—results are usually available within 24–48 hours. After bacterial growth, further identification is done using biochemical tests and by checking whether the strain produces diphtheria toxin (toxigenicity), typically with immunological or PCR methods. Modern techniques such as genetic analysis for the presence of the tox gene, which codes for the diphtheria toxin, are also used. Supportive tests—blood count, inflammatory markers, ECG, or echocardiography in suspected heart complications—are recommended. Diphtheria should be distinguished from other diseases that can cause throat plaques, such as Plaut-Vincent angina, infectious mononucleosis, streptococcal angina, oral candidiasis, or acute tonsillitis. In special cases, especially with atypical presentation or in vaccinated people, additional specialist consultations may be required (e.g. with an ENT or pulmonologist). Every suspected diphtheria case must be immediately isolated and hospitalized to confirm the diagnosis and prevent the infection from spreading. It is also vital to notify sanitary-epidemiological authorities and closely observe contacts. Timely and correct diagnostics, through collaboration between doctors, microbiologists, and laboratory diagnosticians, allow for effective treatment and limit the spread of this dangerous disease.
Diphtheria treatment: effective methods and recommendations
Diphtheria treatment requires urgent action due to the risk of severe complications and high mortality, especially in children and unvaccinated individuals. There are three main pillars of therapy: administration of specific antitoxin serum, antibiotics, and supportive and preventive treatment. The essential element of effective therapy is rapid neutralization of the diphtheria toxin, which is the main cause of life-threatening complications. Antidiphtheria serum (diphtheria antitoxin) must be administered as soon as clinical diagnosis is suspected, without waiting for microbiological test results—any delay reduces treatment effectiveness. The dose depends on severity, location, and duration of symptoms and is determined by a specialist. Serum is given, usually intramuscularly or intravenously; an allergy test is performed beforehand to minimize risk of allergic reactions. Antitoxin therapy is an integral part of treatment, but effectiveness decreases as time passes from the onset of symptoms, so quick medical intervention is essential.
At the same time as antitoxin therapy, targeted antibiotic treatment is started—most often with penicillin group antibiotics (e.g. benzylpenicillin) or macrolides (erythromycin, clarithromycin) for those allergic to penicillin. Antibiotics aim to clear the bacteria from the body, limit disease spread, and reduce the risk of passing the microorganism to others. Treatment usually lasts 10–14 days and is conducted under hospital supervision. Patients are isolated in infectious disease units until all symptoms resolve and negative tests from throat and nose cultures are obtained, usually twice after completing antibiotic therapy. Supportive care—oxygen therapy for people with dyspnea, fluids and nutrients, monitoring heart and respiratory function—is an important part of management. In severe cases, when extensive membranes or acute airway narrowing cause breathing problems, intubation or tracheotomy may be necessary to restore airway patency. Patients with cardiac or neurological complications require specialist consultations and multidisciplinary care including heart monitoring, rhythm management, and rehabilitation. Hospitalization includes strict epidemiological surveillance and isolation of close contacts—all family members, caregivers, and medical staff exposed to the patient must be monitored and given diphtheria vaccine boosters, and, if needed, preventive antibiotics. Strict supervision of all possible contacts and adherence to hygiene rules are vital to limit further spread in the environment. Even after successful antibiotic therapy, a full vaccination course is recommended, as natural disease does not provide lasting immunity. Therefore, proper, rapid, and comprehensive treatment requires close cooperation between doctors, nurses, epidemiological services, and microbiological laboratories.
Why is diphtheria vaccination crucial?
Vaccination against diphtheria is one of the greatest achievements of modern medicine and forms the foundation of effective prevention against this potentially fatal bacterial disease. Prior to vaccines, diphtheria was a leading cause of death among children in central and eastern Europe and a source of serious health complications in adults. Today, regular vaccination has limited cases to isolated incidents or outbreaks among those who are not properly immunized, or in epidemic situations such as sudden population migration or military conflicts. The diphtheria vaccine (often combined with tetanus and pertussis vaccines as DTP or DTaP) works by stimulating the immune system to form lasting immunity to the diphtheria toxin, not the bacterium itself. This means that if exposed, a vaccinated person’s body will not allow toxic infection effects or serious complications, such as heart failure, myocarditis, nerve damage, or even death by airway obstruction, to occur. Vaccination is also hugely important for public health—high coverage leads to so-called herd (population) immunity, indirectly protecting those who cannot be vaccinated for medical reasons, such as newborns, the immunocompromised, or the chronically ill. This minimizes epidemic risk and reduces bacterial spread. A tragic example of diphtheria’s return in a population that neglected vaccination is the 1990s post-Soviet Union outbreak, which resulted in thousands of deaths and hundreds of thousands of hospitalizations and emergency care.
It is important to remember that diphtheria vaccine-induced immunity does not last for life and gradually declines, so booster shots given at regular intervals to children, teenagers, and adults—as per the National Immunization Program—are crucial. In Poland, primary immunization starts in the second month of life, followed by booster doses in infancy and preschool years, then further boosters in school years, and every 10 years in adulthood. Not repeating doses results in waning immunity, putting both the individual and their community at risk. This is particularly relevant in an era of increased global mobility, migration, or health system disruptions. For anyone traveling to regions where diphtheria is still reported (e.g. parts of Asia, Africa, or Eastern Europe), updating vaccinations before travel is essential to protect personal health and prevent domestic outbreaks on return. Modern vaccines are highly effective and safe; adverse effects are rare and usually limited to mild local reactions such as redness or swelling at the injection site. With rising anti-vaccination movements, misinformation, and declining public trust in medical institutions, educating society about the real benefits of vaccination and the risks of neglect is vital. High vaccine coverage remains our best defense against dangerous once-common diseases—such as diphtheria—which although historic, is still potentially deadly in our times.
Complications and prevention of diphtheria – how to stay safe?
Despite advances in medicine and widespread immunization, diphtheria still poses a serious health threat due to the high risk of severe complications that may cause long-term consequences or even death. Particular attention should be given to the toxin produced by Corynebacterium diphtheriae, which leads to the most dangerous outcomes of infection. Among the most common and serious complications is acute inflammation of the heart muscle (diphtheric cardiomyopathy), which typically develops 1–2 weeks after symptom onset and may cause heart rhythm disorders, circulatory failure, or sudden death. Another major complication is damage to the nervous system, especially the peripheral nerves, most often manifesting as cranial nerve palsies (especially the vagus and palatine nerves), leading to swallowing problems, hoarseness, and breathing disturbances. In children, airway obstruction caused by dense, tough-to-remove pseudomembranes is particularly dangerous, especially in the youngest and those with weak immunity. In rare cases, complications also affect the kidneys or other internal organs, resulting in acute multi-organ failure. Untreated or late-diagnosed diphtheria carries a high risk of hospitalization, prolonged recovery, and lasting damage even after acute symptoms have subsided. Secondary bacterial infections, following impaired mucosal function, and the risk of further spread to others—especially in unvaccinated populations—are also of concern.
Effective diphtheria prevention hinges on several pillars, the most important of which is vaccination. In Poland, the regimen includes a combined DTP vaccine (diphtheria, tetanus, pertussis) in several doses during early childhood, with regular boosters during school and adult years. These vaccines induce active immunity, but not lifelong—hence the importance of 10-year boosters, especially for travelers to endemic regions. Beyond vaccination, good personal hygiene and regular handwashing are essential, particularly after contact with possibly sick individuals or respiratory secretions. Rapid response to early symptoms—both in oneself and family members—plus prompt medical consultation can facilitate quick testing and action to stop further spread. During outbreaks in communities, epidemiological surveillance, isolation of sick people, and monitoring of contacts must begin immediately. Those with close contact should get a booster vaccine, and in some cases, preventive antibiotics. Education on the disease, value of vaccination, recognizing symptoms, and understanding the risk must be promoted, especially in low-coverage environments like certain religious groups or conflict zones where logistical support for getting vaccinated is also crucial. Even vaccinated individuals exposed to diphtheria should monitor their health and not ignore mild throat infection symptoms. Globalization, frequent travel, and migration mean a real risk of diphtheria reintroduction to Europe—including Poland—if vaccination levels fall. Only comprehensive prevention—combining vaccination, rapid identification and isolation of cases, and health education—can effectively protect against severe complications and spreading of diphtheria in society.
Summary
Diphtheria is a serious bacterial infectious disease that affects mostly children, but also increases the risk for adults. Early diagnosis and proper treatment are key to avoiding dangerous complications, such as heart or kidney damage. Vaccination remains the most effective means of protection, helping to control outbreak development in Poland. Prevention and awareness of symptoms are the best weapons against diphtheria—keep your vaccinations up to date and respond to any concerning symptoms. Prevention and education can protect you and your children from diphtheria.
